Xiaoqian Huang Selected Research

Antipsychotic Agents (Antipsychotics)

7/2020	Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary.
5/2020	The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats.
3/2019	Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
1/2019	The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats.
1/2018	The antipsychotics sulpiride induces fatty liver in rats via phosphorylation of insulin receptor substrate-1 at Serine 307-mediated adipose tissue insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoqian Huang Research Topics

Disease

8	Neoplasms (Cancer) 01/2024 - 01/2012
3	Liver Neoplasms (Liver Cancer) 04/2022 - 01/2012
3	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 10/2014
3	Hyperprolactinemia 07/2020 - 01/2018
2	Hypoxia (Hypoxemia) 01/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2012
2	Fatty Liver 03/2019 - 01/2018
2	Insulin Resistance 01/2019 - 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Triple Negative Breast Neoplasms 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Pathologic Processes 03/2021
1	Prolactinoma (Prolactinomas) 07/2020
1	Pneumonia (Pneumonitis) 06/2020
1	Pulmonary Atelectasis 06/2020
1	Respiratory Insufficiency (Respiratory Failure) 06/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Bone Diseases (Bone Disease) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Non-alcoholic Fatty Liver Disease 03/2019
1	Liver Diseases (Liver Disease) 03/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Embryonal Rhabdomyosarcoma 01/2016
1	Cholangiocarcinoma 01/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2016
1	Glioma (Gliomas) 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016

Drug/Important Bio-Agent (IBA)

5	Antipsychotic Agents (Antipsychotics)IBA 07/2020 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
3	Triglycerides (Triacylglycerol)IBA 04/2022 - 01/2018
3	Olanzapine (Zyprexa)FDA Link 07/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 07/2020 - 01/2018
2	longdan xiegan tangIBA 05/2020 - 03/2019
2	Insulin (Novolin)FDA Link 01/2019 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 10/2014 - 02/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	ElementsIBA 11/2023
1	LipidsIBA 04/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 03/2021
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	peoniflorinIBA 07/2020
1	ProlactinIBA 07/2020
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 06/2020
1	SolutionsIBA 06/2020
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2020
1	EnzymesIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	GalactosidasesIBA 12/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2019
1	PPAR alphaIBA 03/2019
1	Sterol Regulatory Element Binding Protein 1IBA 03/2019
1	Sulpiride (neogama)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Insulin Receptor Substrate ProteinsIBA 01/2018
1	oil red OIBA 01/2018
1	Semaxinib (SU5416)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Sunitinib (Sutent)FDA Link 01/2016
1	Green Fluorescent ProteinsIBA 01/2012
1	CarcinogensIBA 01/2012

Therapy/Procedure

3	Therapeutics 01/2024 - 10/2014
1	Precision Medicine 01/2024
1	Molecular Targeted Therapy 11/2023
1	Craniotomy 06/2020
1	Length of Stay 06/2020
1	Artificial Respiration (Mechanical Ventilation) 06/2020
1	Transplantation 01/2012